Ignite Creation Date:
2025-12-25 @ 4:16 AM
Ignite Modification Date:
2025-12-26 @ 3:16 AM
Study NCT ID:
NCT03263520
Status:
COMPLETED
Last Update Posted:
2019-02-26
First Post:
2017-08-15
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Impact of the Use of Nandrolone on the Treatment of Malnutrition Induced by Cancer
Sponsor:
Hospital Erasto Gaertner
Organization:
Study Overview
Official Title:
Impact of the Use of Nandrolone on the Treatment of Malnutrition Induced by Cancer
Status:
COMPLETED
Status Verified Date:
2019-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Compare the use of nandrolone associated with corticosteroid for the treatment of cancer-induced malnutrition to treatment with corticosteroids alone in patients with tumors in the high gastro-intestinal tract, liver, pancreas and bile ducts in palliative treatment.
Detailed Description:
* Compare muscle mass values obtained before and after the use of anabolic steroids upon assessment by bioelectrical impedance analysis (BIA).
* Compare the anabolic effect on quality of life (QLo) of the patient before and after the use of anabolic steroids.
* Compare data from laboratory tests such as complete blood count, albumin, C reactive protein and transferrin with drug intervention.
* Compare the anabolic effect on quality of life (QLo) of the patient before and after the use of anabolic steroids.
* Compare data from laboratory tests such as complete blood count, albumin, C reactive protein and transferrin with drug intervention.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: